- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6285
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacotherapy for Nocturia ; volume:19 ; number:1 ; day:9 ; month:2 ; year:2018 ; pages:1-7 ; date:1.2018
Current urology reports ; 19, Heft 1 (9.2.2018), 1-7, 1.2018
- Urheber
-
Andersson, Karl-Erik
- Beteiligte Personen und Organisationen
-
Kerrebroeck, Philip Van
SpringerLink (Online service)
- DOI
-
10.1007/s11934-018-0750-y
- URN
-
urn:nbn:de:1111-2018050911705
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Andersson, Karl-Erik
- Kerrebroeck, Philip Van
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacotherapy for Cluster Headache
Pharmacotherapy for Pediatric Neurogenic Bladder
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Pediatric Convulsive Status Epilepticus
DGI recommendations for COVID-19 pharmacotherapy
Pre-clinical Models for Geriatric Pharmacotherapy
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Pharmacotherapy for obesity: moving towards efficacy improvement
New pharmacotherapy options for noninfectious posterior uveitis
Rhinitis: immunopathology and pharmacotherapy
Pharmacotherapy of gastrointestinal inflammation
Pharmacotherapy for Cluster Headache
Pharmacotherapy for Pediatric Neurogenic Bladder
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Pediatric Convulsive Status Epilepticus
DGI recommendations for COVID-19 pharmacotherapy
Pre-clinical Models for Geriatric Pharmacotherapy
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Pharmacotherapy for obesity: moving towards efficacy improvement
New pharmacotherapy options for noninfectious posterior uveitis
Rhinitis: immunopathology and pharmacotherapy
Pharmacotherapy of gastrointestinal inflammation
Pharmacotherapy for Cluster Headache
Pharmacotherapy for Pediatric Neurogenic Bladder
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Pediatric Convulsive Status Epilepticus
DGI recommendations for COVID-19 pharmacotherapy
Pre-clinical Models for Geriatric Pharmacotherapy
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Pharmacotherapy for obesity: moving towards efficacy improvement
New pharmacotherapy options for noninfectious posterior uveitis
Rhinitis: immunopathology and pharmacotherapy